Page last updated: 2024-10-28

haloperidol and Pheochromocytoma

haloperidol has been researched along with Pheochromocytoma in 5 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courtney, ND1
Howlett, AC1
Westfall, TC1
Hellewell, SB1
Bowen, WD1
Carvey, PM1
McRae, A1
Ptak, LR1
Kao, LC1
Lo, ES1
Goetz, CG1
Tanner, CM1
Penn, RD1
Klawans, HL1
Bräutigam, M1
Laschinski, G1
Kittner, B1
Herken, H1
Yano, S1
Kashima, K1
Daa, T1
Urabe, S1
Tsuji, K1
Nakayama, I1
Yokoyama, S1

Other Studies

5 other studies available for haloperidol and Pheochromocytoma

ArticleYear
Dopaminergic regulation of dopamine release from PC12 cells via a pertussis toxin-sensitive G protein.
    Neuroscience letters, 1991, Jan-28, Volume: 122, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Apomorphine; Cell Line; Dopamine; Dopamine Antagonists; Ergolines;

1991
A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
    Brain research, 1990, Sep-17, Volume: 527, Issue:2

    Topics: Adrenal Gland Neoplasms; Affinity Labels; Animals; Benzomorphans; Binding, Competitive; Brain; Cell

1990
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor.
    Progress in brain research, 1990, Volume: 82

    Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Animals; Autoantibodies; Cells, Cultured; Cerebellum; Corp

1990
Effect of apomorphine, alpha-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cell lines (PC-12 and N1E-115).
    Biochemical pharmacology, 1985, Apr-01, Volume: 34, Issue:7

    Topics: Adrenal Gland Neoplasms; alpha-Methyltyrosine; Animals; Apomorphine; Cell Line; Dihydroxyphenylalani

1985
An antigen retrieval method using an alkaline solution allows immunoelectron microscopic identification of secretory granules in conventional epoxy-embedded tissue sections.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2003, Volume: 51, Issue:2

    Topics: Acrylic Resins; Adrenal Gland Neoplasms; Buffers; Chromogranin A; Chromogranins; Epoxy Resins; Heati

2003